Current Opinion in Immunology

Curr Opin Immunol. 2025 May 30;95:102578. doi: 10.1016/j.coi.2025.102578. Online ahead of print. ABSTRACT The wide spectrum of Sjögren’s disease (SjD) clinical manifestations coupled with its multifaceted pathogenesis has complicated drug target development, optimal clinical trial design, identification of suitable SjD subgroups, selection of appropriate outcome measures, and interpretation of treatment efficacy. Despite recent advancements in … Read more

Curr Opin Immunol. 2025 May 30;95:102577. doi: 10.1016/j.coi.2025.102577. Online ahead of print. ABSTRACT Myasthenia gravis (MG) is an autoimmune disorder characterized by muscle fatigability caused by autoantibodies targeting components of the neuromuscular junction, primarily the acetylcholine receptor (AChR). In AChR-MG, the thymus plays a central role as the initiating site of sensitization, fostering a highly … Read more

Curr Opin Immunol. 2025 May 27;95:102569. doi: 10.1016/j.coi.2025.102569. Online ahead of print. ABSTRACT Prevention remains a critical goal to improve quality of life, given the chronic nature of allergic conditions and the interplay between them contributing to the atopic march. In this review, we will highlight key novel approaches to preventing allergic disease using a … Read more

Curr Opin Immunol. 2025 May 26;95:102570. doi: 10.1016/j.coi.2025.102570. Online ahead of print. ABSTRACT Our body’s mucosal surfaces interface with the external environment and are potential sites of entry for pathogens as well as noxious substances. Yet, these barrier sites are also colonized with symbiotic microbes and are in contact with harmless environmental antigens. Different barrier … Read more

Curr Opin Immunol. 2025 May 26;95:102566. doi: 10.1016/j.coi.2025.102566. Online ahead of print. ABSTRACT Mitochondrial diseases (MtD) provide a unique window into the complex interplay between metabolism and immune function. These rare disorders, caused by defects in oxidative phosphorylation, result in bioenergetic deficiencies that disrupt multiple organ systems. While traditionally studied for their metabolic impact, MtD … Read more

Curr Opin Immunol. 2025 May 24;95:102565. doi: 10.1016/j.coi.2025.102565. Online ahead of print. ABSTRACT Autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis are well-defined autoimmune liver diseases, the pathophysiology of which remains enigmatic. While major therapeutic advances have been achieved for many other autoimmune diseases, precision therapy for these diseases has lagged. For example, limited … Read more

Curr Opin Immunol. 2025 May 22;95:102567. doi: 10.1016/j.coi.2025.102567. Online ahead of print. ABSTRACT The immune response to SARS-CoV-2 has been implicated in the onset of multiple, seemingly unrelated, autoimmune diseases. The immune response to SARS-CoV-2 has also been implicated in the unmasking and/or production of multiple autoantibodies, even in the absence of clinical disease. Despite … Read more

Curr Opin Immunol. 2025 May 20;95:102564. doi: 10.1016/j.coi.2025.102564. Online ahead of print. ABSTRACT IgG4-related disease (IgG4-RD), recognized as a novel clinical entity, is a rare, chronic, immune-mediated systemic fibroinflammatory disorder of unknown origin with either synchronous or metachronous multi-organ involvement. Although the pathogenic mechanism remains unclear, possible multipathogenic factors such as genetic backgrounds, disease-specific or … Read more

Curr Opin Immunol. 2025 May 15;95:102560. doi: 10.1016/j.coi.2025.102560. Online ahead of print. ABSTRACT The COVID-19 pandemic has prompted an unprecedented global response. In particular, extraordinary efforts have been dedicated toward monitoring and predicting variant emergence due to its huge impact, particularly for vaccine escape. Broadly, we classify such methods into two categories: forward mutation prediction, … Read more

Curr Opin Immunol. 2025 May 12;94:102561. doi: 10.1016/j.coi.2025.102561. Online ahead of print. ABSTRACT Rheumatoid arthritis (RA) persists as a chronically progressive autoimmune disorder, notwithstanding significant advancements in early intervention and precision-targeted therapeutics. While treat-to-target paradigms and disease-modifying antirheumatic drugs ameliorate clinical outcomes, sustained drug-free remission (SDFR) or even cure remains elusive, underscoring the need for … Read more